−65JPY
−1.24 BJPY
17.18 M
About CANBAS CO LTD
Sector
Headquarters
Numazu
Employees (FY)
12
Website
Founded
2000
ISIN
JP3244570002
FIGI
BBG000NXL0Z9
CanBas Co., Ltd. engages in pharmaceutical business. It focuses on the research and development of anti-cancer agent, drugs, and technologies which has minor impact on normal cell. Its technologies include drugs for the G2 check point and a screening system to find selective abrogates of the G2 check point. The company was founded by Takumi Kawabe and Masashi Suganuma on January 18, 2000 and is headquartered in Numazu, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4575 is 442.00 JPY — it has decreased by 1.56% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange CANBAS CO LTD stocks are traded under the ticker 4575.
CANBAS CO LTD is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track CANBAS CO LTD financials in yearly and quarterly reports right on TradingView.
Like other stocks, 4575 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CANBAS CO LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 12.00 employees. See our rating of the largest employees — is CANBAS CO LTD on this list?